Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.15 is 72% below its 5-year average of -1.84, near the low end of its 5-year range (-4.48–1.88).
As of the fiscal period ended Wednesday, December 31, 2025. 15.78% above its 12-month average of -3.74.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
-3.15
EARNINGS PER SHARE (EPS) AVG TTM
-3.74
EARNINGS PER SHARE (EPS) AVG 3Y
-3.13
EARNINGS PER SHARE (EPS) AVG 5Y
-1.84
EARNINGS PER SHARE (EPS) AVG 10Y
-1.59
EARNINGS PER SHARE (EPS) AVG 15Y
-0.45
EARNINGS PER SHARE (EPS) AVG 20Y
1.19
CURRENT VS TTM AVG
+15.78%
CURRENT VS 3Y AVG
-0.72%
CURRENT VS 5Y AVG
-71.66%
CURRENT VS 10Y AVG
-98.68%
CURRENT VS 15Y AVG
-603.91%
CURRENT VS 20Y AVG
-363.92%
DENTSPLY SIRONA Inc.
Market Cap
$2.83B
Earnings Per Share (EPS)
-3.15
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$2.82B
Earnings Per Share (EPS)
4.37
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$1.21B
Earnings Per Share (EPS)
-0.99
TTM Avg
-3.50
3Y Avg
-23.24
5Y Avg
-16.84
Market Cap
$464.12M
Earnings Per Share (EPS)
-2.17
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$15.31M
Earnings Per Share (EPS)
-9.05
TTM Avg
-19.23
3Y Avg
-15.56
5Y Avg
-14.25
Market Cap
$6.88B
Earnings Per Share (EPS)
-0.09
TTM Avg
0.57
3Y Avg
0.18
5Y Avg
-0.06
Market Cap
$7.97B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
Market Cap
$8.07B
Earnings Per Share (EPS)
-1.44
TTM Avg
-3.00
3Y Avg
-2.43
5Y Avg
-2.16
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | $2.83B | -3.15 | -3.74 | -3.13 | -1.84 |
| TransMedics Group, Inc. (TMDX)vs › | $2.82B | 4.37 | 3.33 | 1.17 | 0.32 |
| Teladoc Health, Inc. (TDOC)vs › | $1.21B | -0.99 | -3.50 | -23.24 | -16.84 |
| Shoulder Innovations, Inc. (SI)vs › | $464.12M | -2.17 | -1.36 | -1.12 | -1.12 |
| NRC Health (NRC)vs › | $439.47M | 0.25 | 0.79 | 1.03 | 1.18 |
| 23andMe Holding Co. (ME)vs › | $15.31M | -9.05 | -19.23 | -15.56 | -14.25 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.88B | -0.09 | 0.57 | 0.18 | -0.06 |
| Oscar Health, Inc. (OSCR)vs › | $7.97B | -0.54 | -0.79 | -1.41 | -1.76 |
| Tempus AI, Inc. (TEM)vs › | $8.07B | -1.44 | -3.00 | -2.43 | -2.16 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.05B | 6.07 | -18.74 | -45.28 | 14.90 |
Trailing EPS (TTM)
$-3.15
Forward EPS (Est.)
$1.42
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.00 |
| 2024-12-31 | -4.48 |
| 2023-12-31 | -0.62 |
| 2022-12-31 | -4.41 |
| 2021-12-31 | 1.88 |
| 2020-12-31 | -0.38 |
| 2019-12-31 | 1.18 |
| 2018-12-31 | -4.51 |
| 2017-12-31 | -6.86 |
| 2016-12-31 | 1.97 |
| 2015-12-31 | 1.79 |
| 2014-12-31 | 2.28 |
| 2013-12-31 | 2.20 |
| 2012-12-31 | 2.22 |
| 2011-12-31 | 1.73 |
| 2010-12-31 | 1.85 |
| 2009-12-31 | 1.85 |
| 2008-12-31 | 1.90 |
| 2007-12-31 | 1.71 |
| 2006-12-31 | 1.44 |
| 2005-12-31 | 0.29 |
| 2004-12-31 | 1.58 |
| 2003-12-31 | 1.11 |
| 2002-12-31 | 0.95 |
| 2001-12-31 | 0.78 |
| 2000-12-31 | 0.65 |
| 1999-12-31 | 0.57 |
| 1998-12-31 | 0.22 |
| 1997-12-31 | 0.46 |
| 1996-12-31 | 0.42 |
Reported annual fiscal-period values; no daily interpolation.
